Youngy Health Co., Ltd. Stock
Equities
300247
CNE1000015V4
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.510 CNY | -1.10% |
|
-2.38% | -12.09% |
| Capitalization | 3.63B 532M 452M 415M 394M 726M 49.74B 742M 4.87B 1.92B 23.87B 1.99B 1.95B 84.76B | P/E ratio 2024 |
59.7x | P/E ratio 2025 | 57x |
|---|---|---|---|---|---|
| Enterprise value | 3.12B 458M 389M 357M 339M 625M 42.82B 639M 4.19B 1.65B 20.55B 1.72B 1.68B 72.97B | EV / Sales 2024 |
3.2x | EV / Sales 2025 | 3.88x |
| Free-Float |
71.97% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.10% | ||
| 1 week | -2.38% | ||
| Current month | -2.38% | ||
| 1 month | +0.22% | ||
| 3 months | -16.17% | ||
| 6 months | +1.12% | ||
| Current year | -12.09% |
| 1 week | 4.48 | 4.66 | |
| 1 month | 4.22 | 4.73 | |
| Current year | 4.22 | 5.74 | |
| 1 year | 3.42 | 5.98 | |
| 3 years | 2.24 | 5.98 | |
| 5 years | 2.24 | 5.98 | |
| 10 years | 2.24 | 12.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
Han Zhou Xu
CEO | Chief Executive Officer | 51 | 2025-12-22 |
Fen Ling Xing
CEO | Chief Executive Officer | 50 | 2018-10-18 |
| Director | Title | Age | Since |
|---|---|---|---|
Xiang Yang Lv
CHM | Chairman | 65 | 2018-10-18 |
Fen Ling Xing
CHM | Chairman | 50 | 2023-09-10 |
Xiao Dong Qian
BRD | Director/Board Member | 60 | 2022-12-22 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.10% | -2.38% | +32.26% | +28.49% | 532M | ||
| -0.82% | -1.56% | +20.82% | +16.83% | 12.86B | ||
| -0.01% | +0.02% | +19.56% | -8.98% | 9.31B | ||
| -0.98% | -1.73% | +6.92% | -26.98% | 5.89B | ||
| -2.93% | -8.77% | +52.79% | +35.22% | 5.62B | ||
| -1.60% | -1.82% | -16.56% | +51.72% | 5.2B | ||
| -0.37% | -0.85% | -4.07% | +7.69% | 4.79B | ||
| -4.42% | -13.21% | - | - | 3.71B | ||
| -0.56% | -4.47% | +11.38% | -47.13% | 1.74B | ||
| -0.89% | -3.74% | +56.92% | +8.10% | 1.46B | ||
| Average | -1.37% | -2.85% | +20.00% | +7.22% | 5.11B | |
| Weighted average by Cap. | -1.22% | -2.16% | +16.91% | +8.91% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 689M 101M 85.92M 78.81M 74.76M 138M 9.45B 141M 925M 364M 4.53B 379M 371M 16.1B | 933M 137M 116M 107M 101M 187M 12.8B 191M 1.25B 493M 6.14B 513M 503M 21.81B |
| Net income | 46.85M 6.87M 5.84M 5.36M 5.09M 9.38M 643M 9.59M 62.95M 24.77M 308M 25.77M 25.24M 1.1B | 74.8M 10.97M 9.33M 8.56M 8.12M 14.97M 1.03B 15.3M 100M 39.55M 492M 41.14M 40.29M 1.75B |
| Net Debt | -676M -99.09M -84.3M -77.32M -73.36M -135M -9.27B -138M -908M -357M -4.45B -372M -364M -15.8B | -504M -73.96M -62.92M -57.71M -54.75M -101M -6.92B -103M -678M -267M -3.32B -277M -272M -11.79B |
Employees
484
Calendar
03:00am -
Earnings release - Annual 2025
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-04-21 | 4.510 ¥ | -1.10% | 10,615,100 |
| 26-04-20 | 4.560 ¥ | -0.65% | 11,248,200 |
| 26-04-17 | 4.590 ¥ | -1.29% | 11,705,900 |
| 26-04-16 | 4.650 ¥ | +0.87% | 9,748,300 |
| 26-04-15 | 4.610 ¥ | -0.22% | 11,412,200 |
- Stock Market
- Equities
- 300247 Stock
Select your edition
All financial news and data tailored to specific country editions
















